Details
| Stereochemistry | MIXED |
| Molecular Formula | C18H25NO |
| Molecular Weight | 271.3972 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1C2CC3=CC=C(O)C=C3C1(C)CCN2CC4CC4
InChI
InChIKey=YQYVFVRQLZMJKJ-UHFFFAOYSA-N
InChI=1S/C18H25NO/c1-12-17-9-14-5-6-15(20)10-16(14)18(12,2)7-8-19(17)11-13-3-4-13/h5-6,10,12-13,17,20H,3-4,7-9,11H2,1-2H3
Cyclazocine is a mixed opioid agonist/antagonist, an agonist of kappa opioid receptor, and a partial agonist of mu opioid receptor. The drug has analgesic activity and dose 0.25-0.5 mg/70 kg is equivalent to 10 mg/75 kg of morphine. Cyclazocine is a long-acting mu-opioid antagonist in human and was studied for the treatment of addiction to opioids and cocaine. Induction of the drug leads to dysphoria, hallucination, irritability, and sleeplessness.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat. | 1991 |
|
| Differential effects of fedotozine compared to other kappa agonists on diuresis in rats. | 1996 Dec |
|
| Effects of cyclazocine on cocaine self-administration in rats. | 1998 Sep 11 |
|
| Cyclazocine: comparison to hydromorphone and interaction with cocaine. | 2004 Mar |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
||
|
NCI_THESAURUS |
C681
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID9022863
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
100000083727
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
SUB06843MIG
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
222-689-9
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
19143
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
Cyclazocine
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
D003496
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
3572-80-3
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
1664
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
m3968
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
J5W1B1159C
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL56585
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
C80571
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY | |||
|
107429
Created by
admin on Fri Dec 15 16:09:18 GMT 2023 , Edited by admin on Fri Dec 15 16:09:18 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
